The SIGMA Type 2 Diabetes Consortium analyzed 9.2 million SNPs in Latin Americans (3848 diagnosed with T2D and 4366 matched controls) and identified a novel risk variant with four amino acid substitutions in SLC16A11 that was present in 50% of Native American cases of T2D. This evidence concerns the gene SLC16A11 and type 2 diabetes mellitus.